Home / Events / Life Sciences Quarterly Update - Brexit Implications...

Life Sciences Quarterly Update - Brexit Implications for the MedTech Sector

Past event
23 February 2021, 10:30 - 12:00 UTC +01:00

We are delighted to invite you to our life sciences quarterly update webinar, ‘in view’. 

Our CMS team will be evaluating the wide ranging impacts of Brexit for those operating in the MedTech sector. In our webinar we will cover: 

  • Medical device regulation – including CE mark and UKCA mark;
  • IP – including patents, trade secrets, design rights, trade marks and data base rights;
  • Parallel imports and exhaustion of IP rights;
  • Tax – Brexit: a new threat or opportunity?; 
  • Procurement considerations - the UK’s new procurement regime;
  • Environment - RoHS II, III and the UKCA mark in GB after Brexit; and
  • Data protection.

If you would like to attend please register below, or if you would like to invite relevant members of your team please do send the invite on to them.

Webinar
  • 23 February

Speakers

Portrait ofAnna Burchner
Anna Burchner
Partner
London
Portrait ofRachel Free
Dr. Rachel Free
Partner
London
Caroline Hobson
Portrait ofOlivia Jamison
Olivia Jamison
Partner
London
Portrait ofShuna Mason
Shuna Mason
Partner
London
Portrait ofLoretta Pugh
Dr. Loretta Pugh
Partner
London
Portrait ofSarah Wright
Sarah Wright
Partner
London
Portrait ofFionnuala Rice
Fionnuala Rice
Senior Associate
London
Show more Show less